148 related articles for article (PubMed ID: 8558128)
21. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
[TBL] [Abstract][Full Text] [Related]
22. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein.
Balasuriya UB; Patton JF; Rossitto PV; Timoney PJ; McCollum WH; MacLachlan NJ
Virology; 1997 May; 232(1):114-28. PubMed ID: 9185595
[TBL] [Abstract][Full Text] [Related]
23. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge.
Chia SC; Leung PS; Liao CP; Huang JH; Lee ST
Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032
[TBL] [Abstract][Full Text] [Related]
24. Identification of a variant A-specific neutralizing epitope on glycoprotein B (gB) of human herpesvirus-6 (HHV-6).
Takeda K; Okuno T; Isegawa Y; Yamanishi K
Virology; 1996 Aug; 222(1):176-83. PubMed ID: 8813034
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the temperature-sensitive murine cytomegalovirus (MCMV) mutants tsm5 and tsm30: a study of genes involved in immune evasion, DNA packaging and processing, and DNA replication.
Sweet C; Ball K; Morley PJ; Guilfoyle K; Kirby M
J Med Virol; 2007 Mar; 79(3):285-99. PubMed ID: 17245727
[TBL] [Abstract][Full Text] [Related]
26. DNA immunization confers protection against murine cytomegalovirus infection.
González Armas JC; Morello CS; Cranmer LD; Spector DH
J Virol; 1996 Nov; 70(11):7921-8. PubMed ID: 8892915
[TBL] [Abstract][Full Text] [Related]
27. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
Navarro D; Lennette E; Tugizov S; Pereira L
J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
[TBL] [Abstract][Full Text] [Related]
28. A 27 amino acid coding region of JE virus E protein expressed in E. coli as fusion protein with glutathione-S-transferase elicit neutralizing antibody in mice.
Seif SA; Morita K; Igarashi A
Virus Res; 1996 Jul; 43(1):91-6. PubMed ID: 8822638
[TBL] [Abstract][Full Text] [Related]
29. Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes.
Fuchs W; Rziha HJ; Lukàcs N; Braunschweiger I; Visser N; Lütticken D; Schreurs CS; Thiel HJ; Mettenleiter TC
J Gen Virol; 1990 May; 71 ( Pt 5)():1141-51. PubMed ID: 1693164
[TBL] [Abstract][Full Text] [Related]
30. Different antibody response to a neutralizing epitope of human cytomegalovirus glycoprotein B among seropositive individuals.
Ayata M; Sugano T; Murayama T; Sakamuro D; Takegami T; Matsumoto Y; Furukawa T
J Med Virol; 1994 Aug; 43(4):386-92. PubMed ID: 7525866
[TBL] [Abstract][Full Text] [Related]
31. Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.
Cranmer LD; Clark CL; Morello CS; Farrell HE; Rawlinson WD; Spector DH
J Virol; 1996 Nov; 70(11):7929-39. PubMed ID: 8892916
[TBL] [Abstract][Full Text] [Related]
32. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides.
Chassot S; Lambert V; Kay A; Godinot C; Roux B; Trepo C; Cova L
Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963
[TBL] [Abstract][Full Text] [Related]
33. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
Parkinson JE; Smith GL
Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
[TBL] [Abstract][Full Text] [Related]
34. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage.
Spaete RR; Thayer RM; Probert WS; Masiarz FR; Chamberlain SH; Rasmussen L; Merigan TC; Pachl C
Virology; 1988 Nov; 167(1):207-25. PubMed ID: 2460994
[TBL] [Abstract][Full Text] [Related]
35. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance.
Glaser AL; de Vries AA; Dubovi EJ
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2223-33. PubMed ID: 7561759
[TBL] [Abstract][Full Text] [Related]
36. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR
Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423
[TBL] [Abstract][Full Text] [Related]
37. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
38. Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein.
Kropff B; Mach M
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1999-2007. PubMed ID: 9267000
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
40. Characterization of neutralizing monoclonal antibodies to murine cytomegalovirus.
Farrell HE; Shellam GR
J Gen Virol; 1990 Mar; 71 ( Pt 3)():655-64. PubMed ID: 2155998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
